Transdermal Scopolamine Market Opportunity will Rise to US$585.3 mn by 2016 - 2024

Pharmaceuticals

Global Transdermal Scopolamine Market: Snapshot

The global market for transdermal scopolamine is witnessing a remarkable rise, thanks to rising awareness among consumers regarding it being highly effective in treating motion sickness. The increasing number of travelers ... Read more

Submitted by transparency ma... on 2019-05-13 11:22.

Plasma Protease C1-inhibitor Treatment Market to be Worth US US$7.9 bn by 2017-2025

Pharmaceuticals

The vendor landscape of the global market for plasma protease c1-inhibitor treatment market is largely consolidated with a handful of companies collectively accounting for a lion’s share in the market and maintaining a tough level of competition, observes Transparency Market Research in a recent ... Read more

Submitted by transparency ma... on 2019-05-13 11:22.

Subcutaneous Immunoglobulin Market Will be Worth US$8,831.3 Mn by 2016 - 2024

Pharmaceuticals

The global subcutaneous immunoglobulin market has been envisaged in a report by Transparency Market Research (TMR) to witness players relying on steady expansion efforts to cement their position in ... Read more

Submitted by transparency ma... on 2019-05-13 11:22.

Myasthenia Gravis Market to Surge at a CAGR of 10.1% by 2017 - 2025

Pharmaceuticals

Owing to the presence of various big and small players, the market scenario is anticipated to be highly consolidated. The competition in the global myasthenia gravis market seems to be quite tough. Several ... Read more

Submitted by transparency ma... on 2019-05-13 11:22.

Influenza Medication Market will Exhibit a CAGR of 1.4% between 2017 - 2025

Pharmaceuticals

The global market for influenza medication is displaying a highly competitive business structure, finds a new research study by Transparency Market Research (TMR). Daiichi Sankyo Co., GlaxoSmithKline plc, Natco Pharma, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Sandoz ... Read more

Submitted by transparency ma... on 2019-05-13 11:22.

Unfractionated Heparin Market to Reach an Opportunity of US$1664.4 mn by the End of 2025

Pharmaceuticals

Global Unfractionated Heparin Market: Snapshot

Unfractionated heparin is a naturally occurring anticoagulant that is primarily in dialysis and heart lung machines to prevent blood clots as well as for the treatment of blood clotting disorders such as deep venous ... Read more

Submitted by transparency ma... on 2019-05-10 13:59.

Neuroprotection Market to Surge at a CAGR of 8.2% in Terms of Volume by 2025

Pharmaceuticals

Neuroprotection Market: Snapshot

The market for Neuroprotection is expected to grow at steady growth rate during the forecast period largely attributed due to increasing drug development in the pharmaceutical and biotechnology industry along with increasing patient ... Read more

Submitted by transparency ma... on 2019-05-10 13:59.

Label-free Array Systems Market Opportunity will Rise to US$ 1,722.9 Million by 2017 - 2024

Pharmaceuticals

Global Label-free Array System Market: Surface Plasmon Resonance Technology to Witness Rapid Growth through 2024

Label-free array system is being used on the large scale for identifying and validating new molecules for drugs. Label-free technology is suitable for target ... Read more

Submitted by transparency ma... on 2019-05-10 13:59.

Scleroderma Diagnostics and Therapeutics Market is Opportunity will Rise to US$3,663.8 mn by 2024

Pharmaceuticals

Global Scleroderma Diagnostics and Therapeutics Market: Snapshot

The scleroderma therapeutics and diagnostics market exhibits high potential due to untapped needs and is set to grow rapidly in the near future due to the increasing focus globally on treatment of orphan ... Read more

Submitted by transparency ma... on 2019-05-10 13:59.

Pigmentation Disorders Treatment Market is Projected to be Worth US$ 9,268.6 Mn by 2026

Pharmaceuticals

Global Pigmentation Disorders Treatment Market – Snapshot

Pigmentation disorders include a large number of heterogeneous conditions that are usually characterized by altered melanocyte density, melanin concentration, or both, and result in altered pigmentation of the ... Read more

Submitted by transparency ma... on 2019-05-10 13:59.

Thalassemia Treatment Market to Gain US$ 1,639.6 Mn by 2026

Pharmaceuticals

Thalassemia Treatment Market – Snapshot

The global thalassemia treatment market is driven by increase in number of altered thalassemia genes across the globe. The global market was valued at US$ 842.0 Mn in 2017 and is projected to expand at a CAGR of 7.9% from 2018 to ... Read more

Submitted by transparency ma... on 2019-05-10 13:59.

Glaucoma Therapeutics Market is Projected to Report a CAGR of 2.9% between 2018 to 2026

Pharmaceuticals

Glaucoma Therapeutics Market – Snapshot

Glaucoma is a disease that damages the optic nerve and its progression could result in vision loss and blindness. Treatment of glaucoma starts with topical eye drops belonging to the class of prostaglandins, beta blockers, alpha ... Read more

Submitted by transparency ma... on 2019-05-10 13:59.

Geriatric Medicines Market to Surge at a CAGR of 6.1% in Terms of Volume by 2026

Pharmaceuticals

Global Geriatric Medicines Market – Snapshot

Geriatric medicines are a specialty branch of medical science that provides diagnosis and treatment options for the elderly. Most geriatrics are unable to take their medication properly at a scheduled time, due to complex ... Read more

Submitted by transparency ma... on 2019-05-10 13:59.

Drug Eluting Balloon Market to Reach an Opportunity of US$ 1800 Mn by the End of 2026

Pharmaceuticals

Drug Eluting Balloon Market – Snapshot

Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of ... Read more

Submitted by transparency ma... on 2019-05-10 13:59.

Gynecology Drugs Market is likely to be Worth US$ 85,833.02 Mn by the end of 2026

Pharmaceuticals

Global Gynecology Drugs market – Snapshot

Gynecological diseases represent a collective term given to different medical conditions specific to the female reproductive system. Thus, gynecological diseases include conditions affecting the uterus, ovaries and their ... Read more

Submitted by transparency ma... on 2019-05-10 13:59.

Macular Degeneration Treatment Market to Expand at a Modest CAGR of 6.2% by 2026

Pharmaceuticals

Macular Degeneration Treatment Market – Snapshot

The global macular degeneration treatment market was valued at US$ 6.1 Bn in 2017. It is anticipated to reach US$ 11.1 Bn by 2026, expanding at a CAGR of 6.4% from 2018 to 2026. Increase in R&D investments by key ... Read more

Submitted by transparency ma... on 2019-05-10 13:59.

Caspofungin Market is Projected to Expand at a CAGR of 0.18% from 2019 to 2027

Pharmaceuticals

Caspofungin Market – Snapshot

Caspofungin is an antifungal drug that works by inhibiting the enzyme (1→3)-β-D-glucan synthase, thereby disturbing the integrity of the fungal cell wall. Caspofungin acetate was first approved by the U.S. Food and Drug Administration (FDA) on January 26, ... Read more

Submitted by transparency ma... on 2019-05-10 13:59.

Anti-Snoring Devices and Snoring Surgery Market is Rising to a Valuation of US$22.7 Billion in 2024

Pharmaceuticals

The global anti-snoring devices and snoring surgery market depicts a fragmented competitive landscape. The small and large players of the market are focused on innovation to tap growth in ... Read more

Submitted by transparency ma... on 2019-05-09 12:09.

Healthcare Natural Language Processing (NLP) Market to Reach an Opportunity of US$4.3 bn by the End of 2024

Pharmaceuticals

The global healthcare natural language processing (NLP) market is peculiar in itself, majorly due to the complex nature of its offerings. A report by Transparency Market Research (TMR) ... Read more

Submitted by transparency ma... on 2019-05-09 12:09.

Technology Spending on Revenue Cycle Management Market to Reach an Opportunity of US$51.56 bn by the End of 2024

Pharmaceuticals

The global technology spending on revenue cycle management market features an increasingly competitive landscape. Transparency Market Research observes that the entry of several new ... Read more

Submitted by transparency ma... on 2019-05-09 12:09.

Pages